Studies show clomiphene citrate improves sperm parameters in approximately 60-80% of men with oligozoospermia or asthenozoospermia. However, this doesn’t guarantee pregnancy. The actual pregnancy rate using IUI or IVF after clomiphene citrate treatment varies greatly depending on the underlying cause of infertility and the individual’s response to the medication.
Success depends on several factors including the severity of the male infertility, the woman’s fertility, and the chosen assisted reproductive technology (ART) method. For example, men with severe oligospermia may experience lower success rates compared to those with milder cases.
Long-term effects are generally considered minimal for most men. However, some men report temporary side effects like hot flashes, headaches, or visual disturbances during treatment. These usually resolve after the medication is stopped. Long-term studies assessing the potential impact on male reproductive health are limited, but available data does not suggest significant lasting negative consequences in most cases. Always discuss potential risks and benefits with your doctor.
Important Note: Clomiphene citrate doesn’t address all causes of male infertility. It primarily targets issues with sperm production and function. Other conditions may require different treatment approaches. Your doctor will determine if clomiphene citrate is appropriate for your specific situation.
Consult your physician: Before starting clomiphene citrate, a complete evaluation of your reproductive health is necessary to determine the appropriate dosage and treatment duration. Regular monitoring during treatment is also vital to assess your response and adjust the treatment as needed.
